Introduction: When to Seek Diagnostic Evaluation

If you notice certain warning signs related to your urinary system, it’s important to seek medical attention promptly. The most common and often first noticeable symptom of bladder cancer is blood in your urine, which doctors call hematuria. This blood may make your urine appear pink, orange, or darker red. Sometimes the amount of blood is so small that you cannot see it with the naked eye, but it can still be detected through laboratory tests.^[1]

You should contact a healthcare provider if you experience blood in your urine or other symptoms including painful or frequent urination, persistent low back pain, unexplained weight loss, or ongoing fatigue. While these symptoms don’t always mean cancer is present, they warrant a thorough medical evaluation. Men are four times more likely to develop bladder cancer than women, and most people diagnosed are over age 65, though the disease can occur at any age.^[1]

People who smoke cigarettes, work with certain chemicals used in dyes, rubber, leather, paint, textiles, or hairdressing supplies, or have a history of bladder problems may be at higher risk and should be particularly attentive to these symptoms. If you’ve previously had bladder cancer, you’re at increased risk for developing cancer in other parts of the urinary system, making regular monitoring essential.^[1]

Diagnostic Methods for Identifying Bladder Cancer

Urine Tests

The diagnostic process typically begins with tests on your urine. Your healthcare provider will perform a urinalysis, which is a laboratory examination of a urine sample. During this test, the lab technician looks at your urine under a microscope to check for blood cells, infection, and other substances that shouldn’t be there. Even when blood is not visible to the eye, the urinalysis can detect small amounts of red blood cells that might indicate a problem.^[1]

Your doctor may also order specific tests to look for cancer cells in your urine. These specialized urine tests examine the cells that naturally shed from the lining of your bladder into your urine stream. A trained specialist called a pathologist examines these cells under a microscope to determine if any appear abnormal or cancerous. This type of testing is particularly helpful because it’s completely non-invasive, requiring only that you provide a urine sample.^[11]

Imaging Tests

To see inside your body and locate tumors, your healthcare team will use various imaging technologies. A CT scan (computed tomography scan) is one of the most common imaging tests used. This scan uses X-rays taken from different angles and combines them with computer processing to create detailed, three-dimensional pictures of your bladder, kidneys, and surrounding tissues. The CT scan can show the size and location of tumors and whether cancer has spread beyond the bladder wall.^[1]

An MRI (magnetic resonance imaging) scan may also be used. Unlike CT scans, MRI uses powerful magnets and radio waves instead of radiation to create detailed images of soft tissues in your body. This can be particularly useful for seeing how deep a tumor has grown into the bladder wall and whether it has affected nearby organs.^[1]

Your doctor might order an ultrasound, which uses sound waves to create pictures of your internal organs. Ultrasound is painless and doesn’t use radiation. It can help identify masses in the bladder and assess the kidneys and other parts of the urinary system.^[1]

Another specialized imaging test is the intravenous pyelogram (IVP). During this procedure, a contrast dye is injected into a vein in your arm. The dye travels through your bloodstream to your kidneys, ureters, and bladder. X-rays are then taken at specific times as the dye moves through your urinary system. The dye makes these organs stand out clearly on the X-rays and can reveal blockages, tumors, or other abnormalities in your kidneys, ureters, and bladder.^[1]

Scope Examinations and Biopsy

One of the most important diagnostic procedures for bladder cancer is cystoscopy. During this examination, your doctor uses a thin, lighted tube called a cystoscope to look directly inside your bladder. The cystoscope is carefully inserted through your urethra (the tube through which urine exits your body) and advanced into your bladder. The cystoscope has a small camera and light at its tip, allowing your doctor to see the inside lining of your bladder on a video screen.^[1]

During the cystoscopy, if your doctor sees any suspicious areas, they can take small tissue samples called biopsies. These tissue samples are sent to a laboratory where a pathologist examines them under a microscope. The pathologist can determine whether cancer cells are present, what type of cancer cells they are, and how abnormal they look. This information is crucial for understanding the nature of your cancer and planning treatment.^[1]

In many cases, your doctor may perform a procedure called transurethral resection (TUR) or transurethral resection of bladder tumor (TURBT). This procedure serves both diagnostic and treatment purposes. Using instruments passed through the cystoscope, the surgeon removes visible tumors from the bladder lining. The removed tissue is then examined to determine the exact type and stage of cancer. For stage II bladder cancer, the pathologist will confirm that the cancer has grown through the connective tissue into the muscle layer of the bladder wall.^[2]

Determining Stage II Cancer

Stage II bladder cancer, also called muscle-invasive bladder cancer, means that cancer has spread through the connective tissue into the muscle layers of the bladder. The staging process uses information from all the tests mentioned above. Doctors use the TNM staging system, where T stands for tumor, N for lymph nodes, and M for metastasis (spread to distant organs). In stage II bladder cancer, the T stage indicates that cancer has invaded the muscle wall of the bladder, but the cancer has not spread to lymph nodes (N0) or to distant parts of the body (M0).^[2]

The pathologist also assigns a grade to the cancer cells. Cancer cells are graded based on how different they look from normal, healthy cells. High-grade cancer cells look very different from normal cells and tend to grow and spread more aggressively than low-grade cells. Most muscle-invasive bladder cancers, including stage II cancers, are high-grade.^[13]

Diagnostics for Clinical Trial Qualification

If you’re considering participating in a clinical trial for stage II bladder cancer, you’ll need to undergo additional diagnostic testing. Clinical trials are research studies that test new treatments, and they have specific requirements about who can participate. These requirements, called eligibility criteria, help ensure the safety of participants and the accuracy of the study results.

For clinical trials involving stage II bladder cancer, doctors need to confirm the exact stage and characteristics of your cancer. This typically requires a recent biopsy, usually obtained through TURBT, that clearly shows cancer cells have invaded the muscle layer of the bladder. The pathology report from this biopsy must document specific features of the cancer cells, including the cell type (usually urothelial carcinoma), the grade, and the depth of invasion into the bladder wall.^[2]

Imaging studies are crucial for clinical trial enrollment. A recent CT scan or MRI of your abdomen and pelvis is typically required to confirm that the cancer is confined to the bladder and hasn’t spread to nearby lymph nodes or other organs. These scans must usually be performed within a certain timeframe before you can enter the trial, often within 4 to 6 weeks of enrollment.^[2]

Blood tests are standard requirements for most clinical trials. These tests assess your overall health and organ function to ensure you’re healthy enough to tolerate the experimental treatment. Common blood tests include a complete blood count (CBC), which measures different types of blood cells; tests of kidney function, which show how well your kidneys are filtering waste from your blood; and liver function tests, which check how well your liver is working. These tests help doctors determine if your body can handle the treatments being studied.^[13]

Some clinical trials may require additional specialized testing. For example, trials testing treatments that target specific genetic changes in cancer cells may require molecular testing of your tumor tissue. This involves analyzing the DNA of your cancer cells to look for specific mutations or alterations. If your cancer has certain genetic markers, you may be eligible for trials testing targeted therapies designed to attack those specific abnormalities.^[13]

Performance status assessment is another standard part of clinical trial qualification. Your doctor will evaluate your ability to carry out daily activities using standardized scales. This helps determine if you’re healthy and active enough to participate in the trial and tolerate potential side effects of the experimental treatment. Most trials require that participants be able to care for themselves and be active for at least half of their waking hours.

Before entering a clinical trial, you’ll also undergo a thorough medical history review. Your healthcare team will document your previous treatments, other medical conditions, medications you’re taking, and any allergies. This comprehensive evaluation ensures that participating in the trial is safe for you and that you meet all the criteria needed for the study. Some trials exclude patients who have certain other medical conditions or who are taking specific medications that might interfere with the experimental treatment.